Logo
Login

Akero Therapeutics, Inc. DEF 14A SEC Filings

Filed On Filing
28 Apr 2025 Proxy statement: annual meeting on June 3, 2025

CEO pay $10.5M, up 18% · say-on-pay vote
26 Apr 2024 DEF 14A

CEO pay $8.8M, down 15%
28 Apr 2023 DEF 14A
28 Apr 2022 DEF 14A
27 Apr 2021 DEF 14A
27 Apr 2020 DEF 14A

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans